Drug Trial Radar · NCT05071716
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
524
Actual
Start
Apr 7, 2022
Primary completion
Dec 23, 2025
Study completion Dec 23, 2025
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 8, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study RNLC3131 is a Phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of rifaximin SSD-40mg IR for the delay of the first episode of overt hepatic encephalopathy (OHE) decompensation in liver cirrhosis, defined by the presence of medically controlled ascites.
Conditions
- Hepatic Encephalopathy
Interventions
Rifaximin SSDDrug
Rifaximin Solid Soluble Dispersion Immediate Release Twice Daily
PlaceboDrug
Placebo Twice Daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Event of Overt Hepatic Encephalopathy (OHE) Requiring Medical Intervention in the Hospital/Emergency Room (ER)/Emergency Department (ED)/Clinic or DeathTime frame: 72 weeks
Locations
150 sites in 4 countries. Site status is shown where the registry gives one.
Bausch Site 182
Dothan, Alabama
Bausch Site 129
Chandler, Arizona
Bausch Site 103
Peoria, Arizona
Bausch Site 180
Phoenix, Arizona
Bausch Site 153
Phoenix, Arizona
Bausch Site 248
Tempe, Arizona
Bausch Site 222
Tucson, Arizona
Bausch Site 150
Little Rock, Arkansas
Bausch Site 164
Bakersfield, California
Bausch Site 196
Chula Vista, California
Bausch Site 226
Chula Vista, California
Bausch Site 174
Escondido, California
Bausch Site 163
Fresno, California
Bausch Site 242
Garden Grove, California
Bausch Site 115
La Jolla, California
Bausch Site 141
Lancaster, California
Bausch Site 140
Los Angeles, California
Bausch Site 189
Los Angeles, California
Bausch Site 227
Orange, California
Bausch Site 199
Pasadena, California
Bausch Site 119
Redwood City, California
Bausch Site 102
Rialto, California
Bausch Site 177
San Diego, California
Bausch Site 171
San Francisco, California
Bausch Site 214
San Jose, California
Bausch Site 183
Upland, California
Bausch Site 143
Englewood, Colorado
Bausch Site 212
Littleton, Colorado
Bausch Site 151
Bristol, Connecticut
Bausch Site 220
Bradenton, Florida
Bausch Site 257
Cape Coral, Florida
Bausch Site 197
Cutler Bay, Florida
Bausch Site 249
Fort Myers, Florida
Bausch Site 173
Hialeah, Florida
Bausch Site 238
Hialeah Gardens, Florida
Bausch Site 235
Hollywood, Florida
Bausch Site 211
Homestead, Florida
Bausch Site 139
Inverness, Florida
Bausch Site 138
Jacksonville, Florida
Bausch Site 241
Lakewood Rch, Florida
Showing 40 of 150 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.